IONS vs SAVA · rev $514.0M vs $115.0M cap
Ionis Pharmaceuticals Inc (IONS) versus Cassava Sciences Inc (SAVA) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Cassava Sciences Inc (SAVA) is a biotechnology company listed on NASDAQ.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
SAVA does not have a complete income-statement cache yet.
IONS currently screens at market cap $12.28B. SAVA currently screens at market cap $115.0M.
Not investment advice. Open the IONS and SAVA stock pages for the full models.
Not investment advice.